Diabetic Teen from Pune achieves unique feat
Sanofi India Ltd has informed BSE regarding a Press Release dated August 20, 2014, titled "Diabetic Teen from Pune achieves unique feat"20-08-2014
20-08-2014
Sanofi partners with Emcure Pharmaceuticals for marketing and distribution of its oncology portfolio in India
Sanofi India Ltd has informed BSE regarding a Press Release dated August 06, 2014, titled "Sanofi partners with Emcure Pharmaceuticals for marketing and distribution of its oncology portfolio in India"06-08-2014
Board declares Interim Dividend
Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 23, 2014, inter alia, has declared an Interim Dividend of Rs. 10 (Rupees Ten Only) per Equity Share of Rs. 10 for the financial year ending December 31, 2014. The Interim Dividend will be paid on August 14, 2014.23-07-2014
Financial Results & Limited Review for June 30, 2014 (Standalone)
Sanofi India Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2014.23-07-2014
Fixes Record Date for Interim Dividend
Sanofi India Ltd has informed BSE that August 01, 2014 has been fixed as the Record Date for the purpose of Payment of Interim Dividend.18-07-2014
Shareholding Pattern For June 30, 2014
Sanofi India Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.15-07-2014
Board to consider Interim Dividend
Sanofi India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 23, 2014, for:-1. Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2014; and2. Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2014.10-07-2014
Outcome of AGM
Sanofi India Ltd has informed BSE that the 58th Annual General Meeting (AGM) of the Company was held on April 29, 2014.20-05-2014
Renaming of Shareholders / Investors Grievances Committee as the Stakeholders Relationship Committee
Sanofi India Ltd has informed BSE that the Board of Directors of the Company, has, by a resolution passed at its meeting held on April 29, 2014, renamed 'Shareholders / Investors Grievances Committee as the Stakeholders Relationship Committee in compliance with the amended clause 49E(4) of the Listing Agreement.The Stakeholders Relationship Committee comprises of the following Independent Directors:...08-05-2014
Constitution of Corporate Social Responsibility Committee
Sanofi India Ltd has informed BSE that as required by Section 135 of the Companies Act, 2013, the Board of Directors of theCompany has by a resolution passed at its meeting held on April 29, 2014, constituted a Corporate Social Responsibility (CSR) Committee comprising of Mr. Rangaswamy R. lyer, Independent Director, Dr. Shailesh Ayangar, Managing Director and Ms. Virginie Simone Jeanine Verrechia (Ms. Virginie Boucinha), Wholetime Director and Chief Financial Officer....08-05-2014